Price Hikes and Dealmaking Potential Are Key Pharma Catalysts for 2023
![](https://www.mcalindenresearchpartners.com/wp-content/uploads/2023/01/amanda-jones-gmTTQhTq_uM-unsplash-1024x683.jpg)
The biopharma industry is kicking off the year with price hikes and some early signs of a sustained uptick in…
McAlinden Research PartnersJanuary 5, 2023